Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (320/9mcg) Spiromax® and BF (400/12mcg) Turbuhaler® following two inhalations (+/– charcoal [char] block) in healthy volunteers (HV) Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013
Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (160/4.5mcg) Spiromax® and BF (200/6mcg) Turbuhaler® following two inhalations (+/– charcoal [char] block) in healthy volunteers (HV) Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
Is there a difference between the results of the standard six minutes walking test (S6MWT) and the test with ventilation monitoring (V6MWT)? Source: Annual Congress 2011 - Quality control in lung function and exercise-related issues Year: 2011
Detection of the ventilatory compensation point (VCP) during cycling (C) and treadmill (T) incremental exercise Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases Year: 2010
Performance of the 4 meter gait speed test (4MGS) compared to the 6 meters walk test (6MW) in lung pathology Source: International Congress 2019 – Cardiopulmonary exercise testing Year: 2019
Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment Source: Eur Respir J 2007; 30: Suppl. 51, 76s Year: 2007
The effects of adding formoterol (F) and tiotropium (T) on exercise performance and breathlessness in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 577s Year: 2005
Predictive equation for the six minute walk test (6MWT) amongst healthy children (one assessment). SEMIMAP study Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010
Correlation of induced sputum (IS) particles size distribution (PDS) and pulmonary function test (PFT) in asthmatics patients (A-pts) Source: Eur Respir J 2004; 24: Suppl. 48, 604s Year: 2004
Pulmonary function test (PT) and physical fitness (F) in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 395s Year: 2005
Asthma control (AC) 1 year after pulmonary rehabilitation (PR) Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Pharmacokinetics (PK) of single doses of mometasone furoate (MF) delivered via the Breezhaler® (BH) and Twisthaler® (TH) devices in healthy subjects Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Acute effects of tiotropium (T), salmeterol (S) and formoterol (F) on arterial blood gases (ABGs) in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Dose selection and pharmacokinetics of montelukast (sprinkles) in >=6 month to <2 year old asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 525s Year: 2002
Enhanced training on how to use a dry powder inhaler (DPI) improves the inhalation manoeuvre (IM) of patients with asthma (child 6–17 yrs and adult >17 yrs) or COPD and in healthy adults (HA) when they use a Spiromax® (S) and Turbuhaler® (T) DPI Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013
The efficiency of Langerhans‘ cell hystioctosis treatment (3 years follow-up) Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011
Bronchodilator response of single dose of tiotropium (Tio) plus formoterol (Formo) versus four doses of ipratopium (Ipra) plus salbutamol (Salb) over 24 hours in subjects with moderate-to-severe stable COPD Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008
1 Minute Sit-to-Stand Test versus 6 minutes walk test: methods of evaluating exercise capacity in COPD patients Source: International Congress 2017 – Lung function practice in daily life Year: 2017
Reproducibility of resistance (R) and reactance (X) responses to bronchodilator (BD) measured by the impulse oscillation system (IOS) in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005
Rescue2-Monitor (R2M) study: an overview of screened patients. Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021